The Yin and Yang of tyrosine kinase inhibition during experimental polymicrobial sepsis

Cassiano Felippe Gonçalves-de-Albuquerque, Ina Rohwedder, Adriana Ribeiro Silva, Alessandra Silveira Ferreira, Angela R.M. Kurz, Céline Cougoule, Sarah Klapproth, Tanja Eggersmann, Johnatas D. Silva, Gisele Pena de Oliveira, Vera Luiza Capelozzi, Gabriel Gutfilen Schlesinger, Edlaine Rijo Costa, Rita de Cassia Elias Estrela Marins, A. Mócsai, Isabelle Maridonneau-Parini, Barbara Walzog, Patricia Rieken Macedo Rocco, Markus Sperandio, Hugo Caire de Castro-Faria-Neto

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Neutrophils are the first cells of our immune system to arrive at the site of inflammation. They release cytokines, e.g., chemokines, to attract further immune cells, but also actively start to phagocytose and kill pathogens. In the case of sepsis, this tightly regulated host defense mechanism can become uncontrolled and hyperactive resulting in severe organ damage. Currently, no effective therapy is available to fight sepsis; therefore, novel treatment targets that could prevent excessive inflammatory responses are warranted. Src Family tyrosine Kinases (SFK), a group of tyrosine kinases, have been shown to play a major role in regulating immune cell recruitment and host defense. Leukocytes with SFK depletion display severe spreading and migration defects along with reduced cytokine production. Thus, we investigated the effects of dasatinib, a tyrosine kinase inhibitor, with a strong inhibitory capacity on SFKs during sterile inflammation and polymicrobial sepsis in mice. We found that dasatinib-treated mice displayed diminished leukocyte adhesion and extravasation in tumor necrosis factor-a-stimulated cremaster muscle venules in vivo. In polymicrobial sepsis, sepsis severity, organ damage, and clinical outcome improved in a dose-dependent fashion pointing toward an optimal therapeutic window for dasatinib dosage during polymicrobial sepsis. Dasatinib treatment may, therefore, provide a balanced immune response by preventing an overshooting inflammatory reaction on the one side and bacterial overgrowth on the other side.

Original languageEnglish
Article number901
JournalFrontiers in Immunology
Volume9
Issue numberAPR
DOIs
Publication statusPublished - Apr 30 2018

Fingerprint

Yin-Yang
Protein-Tyrosine Kinases
Sepsis
src-Family Kinases
Leukocytes
Cytokines
Inflammation
Abdominal Muscles
Venules
Therapeutics
Phagocytosis
Chemokines
Immune System
Neutrophils
Tumor Necrosis Factor-alpha
Dasatinib

Keywords

  • Dasatinib
  • Inflammation
  • Leukocyte trafficking
  • Sepsis
  • Src tyrosine kinase

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Gonçalves-de-Albuquerque, C. F., Rohwedder, I., Silva, A. R., Ferreira, A. S., Kurz, A. R. M., Cougoule, C., ... de Castro-Faria-Neto, H. C. (2018). The Yin and Yang of tyrosine kinase inhibition during experimental polymicrobial sepsis. Frontiers in Immunology, 9(APR), [901]. https://doi.org/10.3389/fimmu.2018.00901

The Yin and Yang of tyrosine kinase inhibition during experimental polymicrobial sepsis. / Gonçalves-de-Albuquerque, Cassiano Felippe; Rohwedder, Ina; Silva, Adriana Ribeiro; Ferreira, Alessandra Silveira; Kurz, Angela R.M.; Cougoule, Céline; Klapproth, Sarah; Eggersmann, Tanja; Silva, Johnatas D.; de Oliveira, Gisele Pena; Capelozzi, Vera Luiza; Schlesinger, Gabriel Gutfilen; Costa, Edlaine Rijo; Elias Estrela Marins, Rita de Cassia; Mócsai, A.; Maridonneau-Parini, Isabelle; Walzog, Barbara; Rocco, Patricia Rieken Macedo; Sperandio, Markus; de Castro-Faria-Neto, Hugo Caire.

In: Frontiers in Immunology, Vol. 9, No. APR, 901, 30.04.2018.

Research output: Contribution to journalArticle

Gonçalves-de-Albuquerque, CF, Rohwedder, I, Silva, AR, Ferreira, AS, Kurz, ARM, Cougoule, C, Klapproth, S, Eggersmann, T, Silva, JD, de Oliveira, GP, Capelozzi, VL, Schlesinger, GG, Costa, ER, Elias Estrela Marins, RDC, Mócsai, A, Maridonneau-Parini, I, Walzog, B, Rocco, PRM, Sperandio, M & de Castro-Faria-Neto, HC 2018, 'The Yin and Yang of tyrosine kinase inhibition during experimental polymicrobial sepsis', Frontiers in Immunology, vol. 9, no. APR, 901. https://doi.org/10.3389/fimmu.2018.00901
Gonçalves-de-Albuquerque CF, Rohwedder I, Silva AR, Ferreira AS, Kurz ARM, Cougoule C et al. The Yin and Yang of tyrosine kinase inhibition during experimental polymicrobial sepsis. Frontiers in Immunology. 2018 Apr 30;9(APR). 901. https://doi.org/10.3389/fimmu.2018.00901
Gonçalves-de-Albuquerque, Cassiano Felippe ; Rohwedder, Ina ; Silva, Adriana Ribeiro ; Ferreira, Alessandra Silveira ; Kurz, Angela R.M. ; Cougoule, Céline ; Klapproth, Sarah ; Eggersmann, Tanja ; Silva, Johnatas D. ; de Oliveira, Gisele Pena ; Capelozzi, Vera Luiza ; Schlesinger, Gabriel Gutfilen ; Costa, Edlaine Rijo ; Elias Estrela Marins, Rita de Cassia ; Mócsai, A. ; Maridonneau-Parini, Isabelle ; Walzog, Barbara ; Rocco, Patricia Rieken Macedo ; Sperandio, Markus ; de Castro-Faria-Neto, Hugo Caire. / The Yin and Yang of tyrosine kinase inhibition during experimental polymicrobial sepsis. In: Frontiers in Immunology. 2018 ; Vol. 9, No. APR.
@article{7de2c2e15fa8472eb76b0917533448ee,
title = "The Yin and Yang of tyrosine kinase inhibition during experimental polymicrobial sepsis",
abstract = "Neutrophils are the first cells of our immune system to arrive at the site of inflammation. They release cytokines, e.g., chemokines, to attract further immune cells, but also actively start to phagocytose and kill pathogens. In the case of sepsis, this tightly regulated host defense mechanism can become uncontrolled and hyperactive resulting in severe organ damage. Currently, no effective therapy is available to fight sepsis; therefore, novel treatment targets that could prevent excessive inflammatory responses are warranted. Src Family tyrosine Kinases (SFK), a group of tyrosine kinases, have been shown to play a major role in regulating immune cell recruitment and host defense. Leukocytes with SFK depletion display severe spreading and migration defects along with reduced cytokine production. Thus, we investigated the effects of dasatinib, a tyrosine kinase inhibitor, with a strong inhibitory capacity on SFKs during sterile inflammation and polymicrobial sepsis in mice. We found that dasatinib-treated mice displayed diminished leukocyte adhesion and extravasation in tumor necrosis factor-a-stimulated cremaster muscle venules in vivo. In polymicrobial sepsis, sepsis severity, organ damage, and clinical outcome improved in a dose-dependent fashion pointing toward an optimal therapeutic window for dasatinib dosage during polymicrobial sepsis. Dasatinib treatment may, therefore, provide a balanced immune response by preventing an overshooting inflammatory reaction on the one side and bacterial overgrowth on the other side.",
keywords = "Dasatinib, Inflammation, Leukocyte trafficking, Sepsis, Src tyrosine kinase",
author = "Gon{\cc}alves-de-Albuquerque, {Cassiano Felippe} and Ina Rohwedder and Silva, {Adriana Ribeiro} and Ferreira, {Alessandra Silveira} and Kurz, {Angela R.M.} and C{\'e}line Cougoule and Sarah Klapproth and Tanja Eggersmann and Silva, {Johnatas D.} and {de Oliveira}, {Gisele Pena} and Capelozzi, {Vera Luiza} and Schlesinger, {Gabriel Gutfilen} and Costa, {Edlaine Rijo} and {Elias Estrela Marins}, {Rita de Cassia} and A. M{\'o}csai and Isabelle Maridonneau-Parini and Barbara Walzog and Rocco, {Patricia Rieken Macedo} and Markus Sperandio and {de Castro-Faria-Neto}, {Hugo Caire}",
year = "2018",
month = "4",
day = "30",
doi = "10.3389/fimmu.2018.00901",
language = "English",
volume = "9",
journal = "Frontiers in Immunology",
issn = "1664-3224",
publisher = "Frontiers Media S. A.",
number = "APR",

}

TY - JOUR

T1 - The Yin and Yang of tyrosine kinase inhibition during experimental polymicrobial sepsis

AU - Gonçalves-de-Albuquerque, Cassiano Felippe

AU - Rohwedder, Ina

AU - Silva, Adriana Ribeiro

AU - Ferreira, Alessandra Silveira

AU - Kurz, Angela R.M.

AU - Cougoule, Céline

AU - Klapproth, Sarah

AU - Eggersmann, Tanja

AU - Silva, Johnatas D.

AU - de Oliveira, Gisele Pena

AU - Capelozzi, Vera Luiza

AU - Schlesinger, Gabriel Gutfilen

AU - Costa, Edlaine Rijo

AU - Elias Estrela Marins, Rita de Cassia

AU - Mócsai, A.

AU - Maridonneau-Parini, Isabelle

AU - Walzog, Barbara

AU - Rocco, Patricia Rieken Macedo

AU - Sperandio, Markus

AU - de Castro-Faria-Neto, Hugo Caire

PY - 2018/4/30

Y1 - 2018/4/30

N2 - Neutrophils are the first cells of our immune system to arrive at the site of inflammation. They release cytokines, e.g., chemokines, to attract further immune cells, but also actively start to phagocytose and kill pathogens. In the case of sepsis, this tightly regulated host defense mechanism can become uncontrolled and hyperactive resulting in severe organ damage. Currently, no effective therapy is available to fight sepsis; therefore, novel treatment targets that could prevent excessive inflammatory responses are warranted. Src Family tyrosine Kinases (SFK), a group of tyrosine kinases, have been shown to play a major role in regulating immune cell recruitment and host defense. Leukocytes with SFK depletion display severe spreading and migration defects along with reduced cytokine production. Thus, we investigated the effects of dasatinib, a tyrosine kinase inhibitor, with a strong inhibitory capacity on SFKs during sterile inflammation and polymicrobial sepsis in mice. We found that dasatinib-treated mice displayed diminished leukocyte adhesion and extravasation in tumor necrosis factor-a-stimulated cremaster muscle venules in vivo. In polymicrobial sepsis, sepsis severity, organ damage, and clinical outcome improved in a dose-dependent fashion pointing toward an optimal therapeutic window for dasatinib dosage during polymicrobial sepsis. Dasatinib treatment may, therefore, provide a balanced immune response by preventing an overshooting inflammatory reaction on the one side and bacterial overgrowth on the other side.

AB - Neutrophils are the first cells of our immune system to arrive at the site of inflammation. They release cytokines, e.g., chemokines, to attract further immune cells, but also actively start to phagocytose and kill pathogens. In the case of sepsis, this tightly regulated host defense mechanism can become uncontrolled and hyperactive resulting in severe organ damage. Currently, no effective therapy is available to fight sepsis; therefore, novel treatment targets that could prevent excessive inflammatory responses are warranted. Src Family tyrosine Kinases (SFK), a group of tyrosine kinases, have been shown to play a major role in regulating immune cell recruitment and host defense. Leukocytes with SFK depletion display severe spreading and migration defects along with reduced cytokine production. Thus, we investigated the effects of dasatinib, a tyrosine kinase inhibitor, with a strong inhibitory capacity on SFKs during sterile inflammation and polymicrobial sepsis in mice. We found that dasatinib-treated mice displayed diminished leukocyte adhesion and extravasation in tumor necrosis factor-a-stimulated cremaster muscle venules in vivo. In polymicrobial sepsis, sepsis severity, organ damage, and clinical outcome improved in a dose-dependent fashion pointing toward an optimal therapeutic window for dasatinib dosage during polymicrobial sepsis. Dasatinib treatment may, therefore, provide a balanced immune response by preventing an overshooting inflammatory reaction on the one side and bacterial overgrowth on the other side.

KW - Dasatinib

KW - Inflammation

KW - Leukocyte trafficking

KW - Sepsis

KW - Src tyrosine kinase

UR - http://www.scopus.com/inward/record.url?scp=85046644404&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85046644404&partnerID=8YFLogxK

U2 - 10.3389/fimmu.2018.00901

DO - 10.3389/fimmu.2018.00901

M3 - Article

AN - SCOPUS:85046644404

VL - 9

JO - Frontiers in Immunology

JF - Frontiers in Immunology

SN - 1664-3224

IS - APR

M1 - 901

ER -